Chronic Prostatitis and Painful Ejaculation
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterized by pain in the perineum, suprapubic region, testicles or tip of the penis, often exacerbated by ejaculation, and is frequently associated with urinary symptoms without evidence of bacterial infection. 1
Definition and Classification
Chronic prostatitis is categorized into four types according to the National Institutes of Health (NIH):
- Category I: Acute bacterial prostatitis - acute infection with systemic symptoms
- Category II: Chronic bacterial prostatitis - recurrent UTIs with the same pathogen
- Category III: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
- Type IIIa: Inflammatory (white blood cells in semen/prostatic secretions)
- Type IIIb: Non-inflammatory
- Category IV: Asymptomatic inflammatory prostatitis
CP/CPPS (Category III) is the most common form, accounting for 90-95% of prostatitis cases.
Clinical Presentation
Key symptoms of CP/CPPS include:
- Pain in the perineum, suprapubic region, testicles, or penis
- Pain during or after ejaculation (reported in up to 37.2% of patients) 2
- Urinary symptoms (frequency, urgency, hesitancy)
- Sexual dysfunction (erectile dysfunction, premature ejaculation)
Diagnosis
The diagnosis of CP/CPPS is primarily clinical and involves:
- History: Focus on pain characteristics, urinary symptoms, and sexual dysfunction
- Physical examination: Digital rectal examination to assess prostate tenderness
- Basic laboratory tests: Urinalysis and urine culture to exclude infection 1
- NIH-Chronic Prostatitis Symptom Index (NIH-CPSI): To quantify symptoms and monitor treatment response 3
Treatment Approach
First-Line Treatments
Alpha-blockers (alfuzosin, doxazosin, tamsulosin, or terazosin)
- More effective in alpha-blocker-naïve patients
- Longer duration of therapy shows better results 3
Antibiotics (for suspected bacterial component)
Second-Line Treatments
Amitriptyline (Grade B evidence)
- Start at 10 mg and titrate to 75-100 mg if tolerated
- Side effects: sedation, drowsiness, nausea 3
Cimetidine (Grade B evidence)
- Improves symptoms, pain, and nocturia with minimal side effects 3
Pentosan polysulfate (Grade B evidence)
- FDA-approved for interstitial cystitis/bladder pain syndrome
- Requires monitoring for macular damage 3
Physical Therapy and Behavioral Modifications
Pelvic floor muscle relaxation
- Focus on relaxation rather than strengthening exercises 3
- Manual physical therapy targeting pelvic floor muscles for patients with pelvic floor tenderness
Behavioral modifications
- Stress management techniques (meditation, imagery)
- Lifestyle changes: weight loss, regular exercise, smoking cessation
- Dietary modifications and fluid management 3
Special Considerations for Painful Ejaculation
Painful ejaculation is a common symptom in CP/CPPS, affecting approximately 37.2% of patients 2. Consider:
Evaluation for ejaculatory duct obstruction (EDO)
- A potentially correctable cause of CPPS with ejaculatory pain
- Treatable with minor surgery 6
Combined therapy approach
- Triple therapy with doxazosin + ibuprofen + thiocolchicoside has shown significant improvement in pain and voiding symptoms 5
Monitoring and Follow-up
- Use the NIH-CPSI to objectively monitor treatment response
- Expect gradual improvement over time - efficacy of treatments typically increases with duration 5
- Consider referral for specialized interventions if standard treatments fail
Common Pitfalls
Overreliance on antibiotics: CP/CPPS is predominantly non-bacterial, and antibiotics alone often fail to provide relief 5
Neglecting sexual dysfunction: Sexual problems are common in CP/CPPS and should be actively addressed 7, 2
Single-modality treatment: CP/CPPS typically requires a multimodal approach rather than single treatments 3
Unrealistic expectations: Patient education about the chronic nature of the condition and setting realistic expectations for symptom control is essential 3